Clinical Trial Update: Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS [Phase 1, Phase 2]

View source ↗

Summary

An early-stage clinical trial evaluating recombinant human growth hormone therapy for children with Phelan-McDermid Syndrome has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phelan-mcdermid Syndrome

Snippet

Sponsor: Affiliated Hospital of Jiangnan University | Conditions: Phelan-McDermid Syndrome, Growth Hormone Treatment | Phase 1, Phase 2 | Status: COMPLETED